Form4insider filings, from the source

SEC Form 4 · accession 0001232524-17-000146

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Aug 10, 2017A1,365$0.00A13,472D
Ordinary SharesAug 11, 2017S659$142.36D12,813D
Ordinary SharesAug 11, 2017S3$144.112D12,810D
Ordinary SharesF3holding———2,000Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F4$143.66Aug 10, 2017A3,415A—Aug 9, 2027Ordinary Shares3,4153,415D

Explanation of responses